Zoetis (ZTS) Depreciation & Amortization (CF) (2012 - 2026)

Zoetis' (ZTS) quarterly Depreciation & Amortization (CF) came in at $119.0 million in Q1 2026, little changed year-on-year from $119.0 million in Q1 2025, and down 1.65% on a QoQ basis from $121.0 million in Q4 2025.

Zoetis (ZTS) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $119.0 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) changed 0.0% year-over-year to $119.0 million in Q1 2026; TTM through Mar 2026 was $487.0 million, a 0.61% decrease from a year earlier, with the FY2025 full-year figure at $487.0 million, down 2.01% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $119.0 million, down from $121.0 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for ZTS reached as high as $127.0 million in Q2 2024 and fell as low as $114.0 million in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $121.1 million across 5 years, with a median of $121.0 million in 2023.
  • Across the five-year window, Depreciation & Amortization (CF) rose 7.83% in 2023 and decreased 5.56% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $119.0 million in 2022, then grew by 5.88% to $126.0 million in 2023, then retreated by 2.38% to $123.0 million in 2024, then declined by 1.63% to $121.0 million in 2025, then retreated by 1.65% to $119.0 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $119.0 million in Q1 2026, $121.0 million in Q4 2025, and $124.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 4.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 119.00 Mn
Mar 31, 2026 119.00 Mn
Dec 31, 2025 121.00 Mn
Dec 31, 2025 121.00 Mn
Sep 30, 2025 124.00 Mn
Sep 30, 2025 124.00 Mn
Jun 30, 2025 123.00 Mn
Jun 30, 2025 123.00 Mn
Mar 31, 2025 119.00 Mn
Mar 31, 2025 119.00 Mn
Dec 31, 2024 123.00 Mn
Dec 31, 2024 123.00 Mn
Sep 30, 2024 121.00 Mn
Sep 30, 2024 121.00 Mn
Jun 30, 2024 127.00 Mn
Jun 30, 2024 127.00 Mn
Mar 31, 2024 126.00 Mn
Mar 31, 2024 126.00 Mn
Dec 31, 2023 126.00 Mn
Dec 31, 2023 126.00 Mn